跳至主要内容
临床试验/CTRI/2025/03/081558
CTRI/2025/03/081558尚未招募2 期

Randomized control clinical trial to evaluate the efficacy of Haridradi Anjan in Vataja Abhishyanda w.s.r. to Simple Allergic Conjunctivitis

Dr Pragati Audumbar Sarvade1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年3月13日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To Evaluate the Efficacy of Haridradi Anjan in Vataja Abhishyanda w.s.r. to Simple Allergic conjunctivitis.

研究概览

简要总结

This study is single blind randomized control clinical study to evaluate the efficacy of Haridradi Anjan in Simple Allergic Conjunctivitis.

Total 60 patients of age 18 to 50 years of both sex will be randomly selected for this trial and divided into two groups.

Group A  Haridradi Anjan

Dose- 2 Harenu in the evening for 21 days

Group B Olopatadine eye drop

Dose- 2 Drops in the morning and evening for 21 days

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • 18 to 50 years The patients presenting classical signs and symptoms of Vataja Abhishyanda.

排除标准

  • Patients having any other known ocular pathology.
  • Any past or present history of ocular trauma.
  • Patients with K/C/O Naso lacrimal duct block/ Dacryocystitis).

结局指标

主要结局

To Evaluate the Efficacy of Haridradi Anjan in Vataja Abhishyanda w.s.r. to Simple Allergic conjunctivitis.

时间窗: 21 days

次要结局

  • Adverse reaction if any(21 days)

研究者

发起方
Dr Pragati Audumbar Sarvade
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Pragati Audumbar Sarvade

LKR Ayurvedic Mahavidyalaya Post Graduate Training and Research Center, Gadhinglaj, Kolhapur

研究点 (1)

Loading locations...

相似试验